Number of the records: 1  

Neoplasma

  1. TitleNeoplasma
    Subtitlejournal of experimental and clinical oncology
    Author infoCancer Research Institute of the Slovak Academy of Sciences
    ISSN0028-2685
    Year, No.Vol. 71 no. 1 (2024)
    Issue dataBratislava : AEPress . - s. 1-97
    ReferencesPERIODIKÁ-Súborný záznam periodika (0.0-)
    ARTICLES2024:
    Albumin-to-D-dimer rations: A novel prognostic factor for evaluating first-line chemotherapy efficacy in advanced lung adenocarcinoma patients (0.0-),
    Expression patterns and pathogenesis of Semaphorin class 4 subfamily proteins in solid tumors (0.0-),
    microRNA-15a-5p suppresses hypoxia-induced tumor growth and chemoresistance in bladder cancer by binding to eIF5A2 (0.0-),
    Three years follow-up neoadjuvant chemoimmunotherapy in resectable non-small cell lung cancer (0.0-),
    Tiam1 regulates proliferation, invasion, and differentation in neuroblastoma through the Tiam1/Rac1 signaling pathway (0.0-),
    USP36 plays an oncogenic role in colorectal cancer cells (0.0-),
    impact of neo/adjuvant treatment choices on prognosis for surgically treated small-cell neuroendocrine carcinoma of the cervix (0.0-),
    role of HMGA2 in activating the IGFBP2 expression to promote angiogenesis and LUAD metastasis via the PI3K/AKT/VEGFA signaling pathway (0.0-),
    role of polyethylenimine-functionalized gold nanoclusters carrying plasmid CMTM5 in impeding the malignant progression of prostate cancer cells by promoting EGFR endocytosis (0.0-)
    Periodicals statusAccepted (25.04.2024)
    LanguageEnglish
    CountrySlovak Republic
    Copy count1, currently available 0, at library only 1
    Document kindČasopisy
    DatabasePERIODIKÁ - Prijaté čísla
    journal

    journal

                               
    Call numberLocationSublocationInfo
    C 720
    študovňa - časopisy: bežný rok a 3 roky spätne
    		In-Library Use Only
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.

Accept allSettingsReject all